* MDWatch LLC is a patient management platform that provides administrative and operational support to physicians and practitioners employed by MDWatch CA, PC and MDWatch Medical Corp, who deliver care through a telehealth platform. MDWatch LLC does not provide medical or pharmacy services, employ healthcare providers, or influence clinical decision-making. Payment does not guarantee the prescribing or dispensing of medication. The information on this website is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you have questions or concerns about your health, please consult a healthcare professional. This site is an advertisement for telehealth services, and any treatment or prescription is at the sole discretion of the prescribing provider.
* Compounded medications will only be available to patients pursuant to a prescription and only to those who medically qualify after consultation with a healthcare practitioner. Compounded medications are not FDA-approved, which means that they have not undergone review for safety or efficacy by the FDA.
* Copayments, coinsurance, and deductibles may apply to the services provided. The exact amount will depend on your insurance plan and coverage. For more details, please check with your insurance provider or contact our billing team with any questions.
* The price of $90 for a 4-week supply of GLP-1 Core medication is available exclusively to patients outside of California. For California patients with insurance coverage, the price is $129.
* The price is $140 for a 4-week supply of GLP-1 Advanced medication, available exclusively to patients outside of California. For California patients with insurance coverage, the price is $159.
* Compounded medications are not FDA-approved. This means that they have not undergone review for safety or efficacy before being dispensed and have not been demonstrated to FDA to be safe or effective. Novo Nordisk Inc. and Elil Lilly and Company are currently the only companies in the U.S. with FDA-approved products containing Semaglutide (Rybelsus®, Ozempic®, and Wegovy®) and Tirzepatide (Zepbound® and Mounjaro®), respectively. Individual results may vary.
* Most Medicare patients receive significant coverage for MDWatch’s program and services, including chronic condition management, coaching, and virtual consultations. As a courtesy, we will verify your insurance benefits before enrollment to estimate any out-of-pocket costs for these services. If medically appropriate, compounded GLP-1 Core medications may be prescribed. These medications are not covered by Medicare or private insurance. For more details, please check with your insurance provider or contact our billing team.
* The images shown are for marketing purposes only and do not depict actual MDWatch patients.
* Stylized vial or bottle for marketing purposes only; image does not reflect the actual label or size of prescription vial or prescription bottle.
*GLP-1 medications can have serious side effects, including the potential for thyroid tumors. Do not use these medications if you or your family have a history of a type of thyroid cancer known as medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2).
